Epithelial derived tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age = 18 years old; (2) Pathologically diagnosed with epithelial derived tumors, patients who are scheduled for surgical resection/exploration (including primary or recurrent metastatic tumors); (3) Received enhanced CT examination of the lesion site within two weeks; (4) According to the doctor's judgment, the expected survival period is more than 3 months; (5) Voluntary signing of informed consent form; Willing and able to follow the research protocol.
Exclusion criteria
Exclusion criteria: (1) Individuals with a known history of allergies to 68Ga-FT-FAPI and 18F-FT-FAPI and their excipients; (2) Individuals who cannot tolerate intravenous administration methods (such as a history of fainting or bleeding); Researchers believe that imaging examinations such as PET are not suitable or cannot be completed due to special reasons, including claustrophobia, radiation phobia, etc; (3) Patients who have received anti-tumor therapy before examination, or who have received neoadjuvant chemotherapy/targeted therapy for tumor reduction from examination to surgery; (4) Pregnant and lactating women; (5) Practitioners who require long-term exposure to radioactive conditions; (6) Serious diseases such as heart, kidney, lungs, blood vessels, nerves, and mental system, immunodeficiency diseases, and hepatitis/cirrhosis; (7) Participated in other intervention clinical trials within the first month prior to screening; (8) Patients undergoing chemotherapy, immunotherapy, or molecular targeted therapy; (9) There are other situations where the researcher deems it unsuitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax; | — |
Countries
China
Contacts
the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University